Titlebook: Biomaterials for Clinical Applications; Sujata K. Bhatia Book 2010 Springer Science+Business Media, LLC 2010 AIDS.Bioengineering.Biomateri

abreast

Introduction,asure how many people die each year and track the causes of death. Such numbers provide a meaningful, concrete basis for guiding not only public health actions but also biomedical science and technology development. In late 2008, the World Health Organization (WHO) published the most recent update t

lacrimal-gland

Pneumonia,ere responsible for 4.2 million deaths, or 7.1% of all deaths globally (World Health Organization 2008). Notably, these infections of the lung affect the old as well as the young and account for nearly 10% of all years of life lost globally. Of the 4 million people who die every year from pneumonia,

掙扎

金盤是高原

HIV/AIDS,use of death worldwide. In 2004, HIV/AIDS was responsible for 2 million deaths, or 3.5% of all deaths globally (World Health Organization 2008). Because HIV/AIDS affects children as well as adults, the disease accounts for 5.6% of all years of life lost globally, a disproportionately high amount (Wo

NICE

Tuberculosis, all deaths globally (World Health Organization 2008). The tuberculosis epidemic affects a staggering number of people: at any given time, 13.7 million individuals worldwide suffer from tuberculosis (World Health Organization 2009a). The global incidence of tuberculosis is equally significant, with

integrated

perjury

啤酒

引起痛苦

Conclusion,sical sciences. Innovative biomaterials can allow individuals to live longer and healthier lives, as demonstrated by the technologies and case studies contained within this book. Biomaterials have sufficient versatility to tackle infectious diseases, chronic degenerative diseases, developmental diso

Biomarker